zika

Funding Alert: Contact Congress for Emergency Funding for Zika

Please contact Congress to urge the immediate passage of a bipartisan emergency supplemental bill for Zika.
Take Action

ASM Acts to Counter Zika Virus Outbreak

The emerging threat of Zika virus infection.
Read

ASM Urges Action to Combat Zika Emergency

Current events linked to the Zika virus make aggressive public health actions and funding to combat this emerging infectious disease more crucial than ever.
Read
New Governance Information
VOTE
Become a member today!
JOIN ASM
Submit Abstracts for ABRCMS
SUBMIT
Register for ABRCMS
REGISTER

Federal Register Notice

In October 1998, the ASM was awarded representation on the Laboratory Negotiated Rulemaking Committee (NRC) which negotiated with selected organizations on drafting national coverage determinations (NCD) and administrative policies for clinical laboratory tests reimbursed under Medicare. Vickie Baselski, Member, Committee on Professional Affairs, Public and Scientific Affairs Board was the ASM representative to the NRC. ASM was also chosen to Chair the Infectious Disease Workgroup which was charged with prioritizing specific infectious disease diagnostic services and drafting national reimbursement policies. The Committee met eight times before January 1, 1999 and reached consensus on national coverage and administrative policies for clinical diagnostic laboratory services which simplified current administrative requirements and facilitated appropriate reimbursement.

On November 23, the Centers for Medicare and Medicaid Services (CMS) published "Medicare Program; Negotiated Rulemaking: Coverage and Administrative Polices for Clinical Diagnostic Laboratory Services; Final Rule" in the Federal Register. The rule establishes national coverage and administrative policies for clinical diagnostic laboratory services payable under Medicare Part B to promote Medicare program integrity and national uniformity, and simplify administrative requirements for clinical diagnostic laboratory services. The ASM was a member of the Negotiated Rulemaking Committee (NRC) and chaired the Infectious Disease Workgroup which was responsible for prioritizing specific infectious disease diagnostic services and drafting national reimbursement and administrative policies which are included in the final rule.

The ASM chaired the Infectious Disease Workgroup which drafted the national reimbursement and administrative policy for Urine Cultures.

TPL_asm2013_SEARCH

2691